CD47-SIRPα checkpoint disruption in metastases requires tumor-targeting antibody for molecular and engineered macrophage therapies

Name: CD47-SIRPα checkpoint disruption in metastases requires tumor-targeting antibody for molecular and engineered macrophage therapies
Creator: Andrechak, Jason; Zhang, William; Discher, Dennis; Tobin, Michael; Hayes, Brandon; Dooling, Lawrence J.; Lee, Justine; Irianto, Jerome; Jin, Xiaoling
Published: 2022-04-08T00:00:00+08:00

Figshare2022-04-08 更新2026-04-08 收录

肿瘤免疫检查点阻断

巨噬细胞治疗

数据链接：

https://figshare.com/articles/dataset/CD47-SIRP_checkpoint_disruption_in_metastases_requires_tumor-targeting_antibody_for_molecular_and_engineered_macrophage_therapies/19358786/1 数据链接链接失效反馈

官方服务：

资源简介：

Data for the Cancers (2022) publication: CD47-SIRPα checkpoint disruption in metastases requires tumor-targeting antibody for molecular and engineered macrophage therapies

提供机构：

Andrechak, Jason; Zhang, William; Discher, Dennis; Tobin, Michael; Hayes, Brandon; Dooling, Lawrence J.; Lee, Justine; Irianto, Jerome; Jin, Xiaoling

创建时间：

2022-04-08